Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathel Kerr

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|April 17, 2007
Satraplatin for hormone-refractory prostate cancerCathel Kerr
The Lancet. Oncology|November 15, 2006
New genetic test for Lynch syndromeCathel Kerr
The Lancet. Oncology|May 14, 2005
Bevacizumab and chemotherapy improves survival in NSCLCCathel Kerr
The Lancet. Oncology|May 16, 2006
Improved survival and response to hepatic infusionCathel Kerr
The Lancet. Oncology|April 8, 2006
New findings for hormone-resistant prostate cancerCathel Kerr
The Lancet. Oncology|September 10, 2002
Huntington's disease provides cancer cluesCathel Kerr
Trends in Endocrinology and Metabolism: TEM|August 21, 2002
Depression eased for Parkinson malesCathel Kerr
The Lancet. Oncology|June 18, 2002
'Rub on' treatment for basal-cell carcinomaCathel Kerr
The Lancet. Oncology|July 31, 2002
(223)Ra targets skeletal metastases and spares normal tissueCathel Kerr
The Lancet. Oncology|March 8, 2003
Endonasal surgery for pituitary tumours replaces 40-year standardCathel Kerr
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|April 17, 2007
Satraplatin for hormone-refractory prostate cancerCathel Kerr
The Lancet. Oncology|November 15, 2006
New genetic test for Lynch syndromeCathel Kerr
The Lancet. Oncology|May 14, 2005
Bevacizumab and chemotherapy improves survival in NSCLCCathel Kerr
The Lancet. Oncology|May 16, 2006
Improved survival and response to hepatic infusionCathel Kerr
The Lancet. Oncology|April 8, 2006
New findings for hormone-resistant prostate cancerCathel Kerr
The Lancet. Oncology|September 10, 2002
Huntington's disease provides cancer cluesCathel Kerr
Trends in Endocrinology and Metabolism: TEM|August 21, 2002
Depression eased for Parkinson malesCathel Kerr
The Lancet. Oncology|June 18, 2002
'Rub on' treatment for basal-cell carcinomaCathel Kerr
The Lancet. Oncology|July 31, 2002
(223)Ra targets skeletal metastases and spares normal tissueCathel Kerr
The Lancet. Oncology|March 8, 2003
Endonasal surgery for pituitary tumours replaces 40-year standardCathel Kerr
Pageof 5